Roles of Epithelial-Mesenchymal Transition in Cancer Drug Resistance

Author(s): Yulong Shang, Xiqiang Cai, Daiming Fan

Journal Name: Current Cancer Drug Targets

Volume 13 , Issue 9 , 2013

Become EABM
Become Reviewer


Overcoming intrinsic and acquired drug resistance is a major challenge in treating cancer. Poor responses to drug treatment can result in metastasis, cancer dissemination and death. Recently, the epithelial-mesenchymal transition (EMT) has been found to play a critical role in cancer drug resistance, but the nature of this intrinsic link remains unclear. This review summarizes recent advances in the understanding of drug resistance and focuses especially on the association between EMT and drug resistance. We discuss the roles of EMT in regulating drug resistance across different types of cancer, focusing simultaneously on the molecular mechanisms and potential pathways involved in the regulation of drug resistance by EMT. In addition, we discuss potential therapeutic strategies to target EMT to reverse drug resistance.

Keywords: BCL-2, Cancer stem cell, drug resistance, EMT, microRNA, NF-B, P-glycoprotein.

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2013
Published on: 12 December, 2013
Page: [915 - 929]
Pages: 15
DOI: 10.2174/15680096113136660097
Price: $65

Article Metrics

PDF: 117